Cite

HARVARD Citation

    Hsu, K. et al. (2019). High PD-L1 expression correlates with primary resistance to EGFR-TKIs in treatment naïve advanced EGFR-mutant lung adenocarcinoma patients. Lung cancer. pp. 37-43. [Online]. 
  
Back to record